Total Payments
$53,721
2024 Payments
$38.96
Companies
19
Transactions
104
Medicare Patients
417
Medicare Billing
$131,733
Payment Breakdown by Category
Consulting$41,850 (77.9%)
Travel$7,842 (14.6%)
Food & Beverage$3,108 (5.8%)
Other$850.00 (1.6%)
Education$70.09 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,850 | 14 | 77.9% |
| Travel and Lodging | $7,842 | 28 | 14.6% |
| Food and Beverage | $3,108 | 58 | 5.8% |
| Honoraria | $850.00 | 3 | 1.6% |
| Education | $70.09 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Edwards Lifesciences Corporation | $48,811 | 76 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $1,875 | 1 | $0 (2021) |
| Bard Access Systems, Inc. | $600.00 | 2 | $0 (2020) |
| Medtronic, Inc. | $516.67 | 1 | $0 (2021) |
| Vertex Pharmaceuticals Incorporated | $508.33 | 1 | $0 (2023) |
| BARD PERIPHERAL VASCULAR, INC. | $300.00 | 1 | $0 (2019) |
| Resmed Corp | $250.00 | 1 | $0 (2022) |
| Covidien LP | $201.55 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $155.26 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $121.22 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38.96 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($23.84) |
| 2023 | $6,890 | 9 | Edwards Lifesciences Corporation ($6,360) |
| 2022 | $1,142 | 6 | Edwards Lifesciences Corporation ($754.78) |
| 2021 | $5,480 | 6 | Edwards Lifesciences Corporation ($3,050) |
| 2020 | $13,958 | 12 | Edwards Lifesciences Corporation ($13,561) |
| 2019 | $19,981 | 27 | Edwards Lifesciences Corporation ($19,410) |
| 2018 | $4,959 | 31 | Edwards Lifesciences Corporation ($4,571) |
| 2017 | $1,271 | 11 | Edwards Lifesciences Corporation ($1,105) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: DIABETES | ||||||
| 08/31/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/26/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $508.33 | General |
| 03/16/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $91.83 | General |
| 03/16/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $60.84 | General |
| 03/16/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $58.24 | General |
| 03/16/2023 | Edwards Lifesciences Corporation | — | Travel and Lodging | In-kind items and services | $25.00 | General |
| 03/16/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $5.74 | General |
| 02/02/2023 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 02/02/2023 | Edwards Lifesciences Corporation | — | Travel and Lodging | Cash or cash equivalent | $118.39 | General |
| 10/17/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $121.22 | General |
| 10/05/2022 | Edwards Lifesciences Corporation | — | Travel and Lodging | In-kind items and services | $240.35 | General |
| 09/19/2022 | Edwards Lifesciences Corporation | — | Travel and Lodging | In-kind items and services | $440.81 | General |
| 07/29/2022 | Resmed Corp | AIR 11 (Device) | Honoraria | Cash or cash equivalent | $250.00 | General |
| Category: Sleep | ||||||
| 05/14/2022 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $73.62 | General |
| 02/23/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/23/2021 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 10/08/2021 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $516.67 | General |
| 06/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| 03/18/2021 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| 02/19/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/14/2020 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| 11/05/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 56 | 119 | $56,525 | $19,949 |
| 2022 | 2 | 108 | 246 | $158,195 | $41,894 |
| 2021 | 2 | 83 | 136 | $100,760 | $24,010 |
| 2020 | 4 | 170 | 294 | $184,640 | $45,881 |
Total Patients
417
Total Services
795
Medicare Billing
$131,733
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 56 | 119 | $56,525 | $19,949 | 35.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 96 | 224 | $150,320 | $39,882 | 26.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 12 | 22 | $7,875 | $2,012 | 25.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 72 | 122 | $95,160 | $22,640 | 23.8% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 11 | 14 | $5,600 | $1,370 | 24.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 92 | 199 | $155,220 | $37,752 | 24.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 36 | 39 | $11,310 | $3,462 | 30.6% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 24 | 34 | $13,600 | $3,294 | 24.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 22 | $4,510 | $1,373 | 30.4% |
About Dr. Herbert Patrick, MD
Dr. Herbert Patrick, MD is a Pulmonary Disease healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811938558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Herbert Patrick, MD has received a total of $53,721 in payments from pharmaceutical and medical device companies, with $38.96 received in 2024. These payments were reported across 104 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($41,850).
As a Medicare-enrolled provider, Patrick has provided services to 417 Medicare beneficiaries, totaling 795 services with total Medicare billing of $131,733. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Philadelphia, PA
- Active Since 06/10/2006
- Last Updated 08/17/2007
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1811938558
Products in Payments
- EV1000 Clinical Platform (Device) $1,450
- HemoSphere advanced monitoring platform (Device) $670.61
- ClearSight System (Device) $443.60
- POWERGLIDE (Device) $300.00
- AIR 11 (Device) $250.00
- Nellcor (Device) $201.55
- OFEV (Drug) $95.10
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $78.49
- XARELTO (Drug) $72.55
- CCOmbo V Pulmonary Artery Catheters (Device) $72.38
- Nephrocheck (Device) $70.09
- AVYCAZ (Drug) $50.84
- FloTrac Sensor (Device) $38.01
- ELIQUIS (Drug) $27.49
- TEFLARO (Drug) $24.66
- JARDIANCE (Drug) $23.84
- Circulatory Support (Device) $22.99
- ENTRESTO (Drug) $17.53
- Kcentra (Biological) $16.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Philadelphia
Gerard Criner, Md, MD
Pulmonary Disease — Payments: $945,674
Pulmonary Disease $945,674
Jeffrey Edelson, M.d, M.D
Pulmonary Disease — Payments: $437,125
Pulmonary Disease $437,125
Steven Geller, Do, DO
Pulmonary Disease — Payments: $251,222
Pulmonary Disease $251,222
Parth Rali, Md, MD
Pulmonary Disease — Payments: $232,570
Pulmonary Disease $232,570
Boyd Hehn, Md, MD
Pulmonary Disease — Payments: $139,719
Pulmonary Disease $139,719
Edward Schulman, Md, MD
Pulmonary Disease — Payments: $132,370
Pulmonary Disease $132,370